Drugs / H-100
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02072018 Comparator | Jun → Dec 2013 | Peyronie disease | Hybrid Medical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H-100 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02072018 ↗ |
| Modality | Small molecule | — CHEMBL4802134 ↗ |